FDA APPROVES ATRALIN™ (tretinoin) GEL 0.05 FROM CORIA LABORATORIES FOR ACNE VULGARIS

Coria Laboratories, Ltd.
 
Press Release
Brief Description		 Coria Laboratories announced today that the Food and Drug Administration (FDA) has given approval for Atralin™ (tretinoin) Gel 0.05, a new drug for use in the topical treatment of acne vulgaris.

 
FREE Registration is required for full site access

Already a member? Click Here to login